Introduction
Cordocentesis for prenatal diagnostic purposes has been already considered and experienced during the seventies while performing fetoscopy. The crucial argument for the generally agreement of non-acceptance of this technique was the relatively extremely high incidence of termination of the pregnancy as a complication of the procedure (up to 11.3%) [24] . This major complication made fetoscopy to be practiced only by minor groups of perinatologists.
In 1983 the first cordocentesis under real-time ultrasonic guidance was described [3] . Since then the technique has been practiced all over the world as a diagnostic tool for intrauterine infections [5, 12] , hematological disorders [1, 2, 3, 5, 7, 12, 14], metabolic status and blood gases of the fetus [1, 12, 15, 18] and rapid cytogenetic analysis [1, 5, 12, 20] . The purpose of this paper is to report our experience in performing this method for prenatal diagnosis over the last three years.
Materials and methods
Between December 1985 and December 1988 one hundred and ninety eight (198) cordocentesis were performed in an ambulatory program.
Preliminary maternal blood analysis includes: blood group, Rh factor and mean corpuscular volume (mcv). An ultrasonic screening of all fetal organs is performed prior to the final determination of the umbilical-cord insertion-sight into the placenta. After cleaning the abdomen with Iodine solution, the ultrasonic (3.5 mHz) transducer is being held in a sterile nylon bag and a repeated focusing of the insertion point is made (using sterile gel for the transducer).
A 21 gauge spinal needle, previously washed with heparin or citrate, is inserted via the optimal point on the maternal abdomen. Under real time ultrasonic guidance it is possible to follow the needle to the exact puncturing sight. An assistant must aid in aspirating the fetal blood while the needle is being located in the umbilical vessel. An immediate blood analysis is being performed for mcv of the erythrocytes, in purpose to fully confirm that fetal blood has been aspirated.
Fetal monitoring routinely follows cordocentesis: ultrasonic real-time fetal heart and body movements visualization, and NST at gestational age more than 26 weeks. Termination of the pregnancy was directly related to the procedure itself in only two cases (1.0%). In a case where cytogenetic analysis revealed Trisomy 21, septic fever was noted three days after the cordocentesis. In the second case premature rupture of the membranes occured ten days after the cordocentesis accompanied by premature contractions. Considering the premature gestational age (23rd week), tocolysis was Only in one case intra uterine fetal death occured a short time after the cordocentesis. In this case a fetus of 25 gestational weeks with sever oligohydramnios and IUGR was diagnosed to suffer from metabolic acidosis (pH = 7.01). Seven cases in the total group described are still pregnant (all had cordocentesis more than a month before their inclusion in this study).
Discussion
Our preliminary experience with cordocentesis indicate that considering the advantages of the method the procedure itself is easy for routine practice. The success rate of the procedure is high and is similar to the results published by others [2, 5, 12]. Success of cordocentesis mainly depends on the reliability and technical as well as clinical skills of the performer. Another crucial factor for success is localization of the optimal site for the puncturing: one should rule out that the needle is indicated to a free loop of the umbilical cord. In cases of a placenta located in the posterior uterine wall and at that time the fetal presentation does not let resonable imaging of the puncturing site, one should not try unnecessary maneuvers and the cordocentesis should be postponed. Upon a spontaneous or externally induced change in anatomical position, it is possible to re-evaluate the optimal site for insertion of the needle. 
